mindful impending phase out certain controlled substances parties operating paragraph article desiring implement effectively paragraph decision iv make currently used essential use exemption process related decisions fully applicable parties operating paragraph article subject phase out dates applicable parties parties operating taking consideration parties operating paragraph article may prepare essential use nominations first time may therefore face difficulties so make following modifications decisions noted below remove reference term operating article or non parties following titles provisions following past decisions parties decisions viii viii viii xi xvii xviii xix ii decision viii first line paragraphs iii decision xv paragraphs iv decision xviii paragraphs decision xviii first line paragraph remove reference term operating article montreal protocol following titles provisions following past decisions parties decision xvii paragraph ii decision xix paragraphs remove replace reference date term out following provisions past decisions parties decision xvii paragraph ii decision xviii paragraph iii decision xix paragraph add new paragraph paragraph decision xvii read follows bis reference paragraph decision xv request parties operating paragraph article montreal protocol submit date ozone secretariat prior twenty second meeting parties time regulation regulations determine non vast majority chlorofluorocarbons metered dose inhalers active ingredient solely salbutamol proposed add new paragraph paragraph decision ix read follows bis require parties operating paragraph article submitting essential use nominations chlorofluorocarbons metered dose inhalers treatment asthma chronic obstructive pulmonary disease present ozone secretariat initial national regional transition strategy january circulation parties possible parties operating paragraph article encouraged develop submit secretariat initial transition strategy preparing transition strategy parties operating paragraph article take consideration availability price treatments asthma chronic obstructive pulmonary disease countries currently importing chlorofluorocarbon containing metered dose inhalers add new paragraph paragraph decision xii read follows bis chlorofluorocarbon metered dose inhaler product approved excluding product process registration approved treatment asthma and or chronic obstructive pulmonary disease party operating paragraph article essential use unless product meets criteria set paragraph decision iv add new paragraph paragraph decision xv read follows bis quantity chlorofluorocarbons essential uses shall authorized commencement twenty first meeting parties nominating party operating paragraph article submitted ozone secretariat time consideration parties twenty ninth meeting open ended working group preliminary plan action regarding phase out domestic use chlorofluorocarbon metered dose inhalers sole active ingredient salbutamol parties submitting nominations essential use exemptions technology economic assessment panel reviewing nominations essential use exemptions shall consider decisions noted amended form considering essential use nominations beyond subject future decisions parties request secretariat include changes relevant decisions parties contained montreal protocol handbook time next revision note handbook related decisions include modifications adopted present decision request technology economic assessment panel reflect paragraphs revised version handbook essential use nominations submit consideration parties suggestions appropriate changes handbook timing make changes